Clinical Trial Update: Omarigliptin Add-on to Insulin in Japanese Participants With Type 2 Diabetes Mellitus (T2DM, MK-3102-039) [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating add-on omarigliptin to insulin in Japanese participants with type 2 diabetes mellitus; results completed with posted results in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Omarigliptin (omarigliptin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2019-09-19